Internal Medicine · 1998 · 20 citations · 13 references
ImmunologyHepatitis BPathologyCyclosporin ALiver DysfunctionImmunotherapyCirrhosisSteroid TherapyAutoimmune Liver DiseaseHepatic DisordersViral HepatitisHbv-dna LevelsAutoimmune DiseaseLiver PhysiologyAutoimmunityChronic Viral InfectionHepatologyImmunosuppressive TherapyPathogenesisHepatitisComplications Of CirrhosisAcute Liver FailureLiver DiseaseImmunosuppressionMedicine
A 57-year-old woman was admitted with symmetrical proximal muscle weakness, liver dysfunction, abnormal muscle enzymes, and she was an antibody to hepatitis B e (anti-HBe) positive hepatitis B virus (HBV) carrier. Biopsy of her left quadriceps femoris showed myositis, so prednisolone was started at 40 mg/day. However, her hepatic function deteriorated and liver biopsy after 4 months showed acute hepatitis with partial submassive necrosis. Treatment with interferon-alpha and cyclosporin A progressively reduced the transaminase and HBV-DNA levels. Early treatment with interferon-alpha plus cyclosporin A can control exacerbation of hepatitis B.
13
Classification of chronic hepatitis: Diagnosis, grading and staging
Valeer Desmet, Michael A. Gerber, Jay H. Hoofnagle et al. · Hepatology · 1994 · 2.6K citations
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection
G. Realdi, A. Albertí, Massimo Rugge et al. · Gastroenterology · 1980 · 434 citations
Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy
J H Hoofnagle, Geoffrey Dusheiko, Daniel F. Schafer et al. · Annals of Internal Medicine · 1982 · 400 citations
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe
Ferruccio Bonino, Floriano Rosina, Mario Rizzetto et al. · Gastroenterology · 1986 · 334 citations